Attachment of hyaluronan to metallic surfaces

Journal of Biomedical Materials Research - Part A

Volumn 68, Issue 1, 2004, Pages 95-106

  Pitt, William G ^a   Morris, Robert N ^a,c   Mason, Mitchell L ^a,c   Hall, Matthew W ^a,c   Luo, Yi ^b,d   Prestwich, Glenn D ^b  

^a Department of Electrical and Computer Engineering   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c INTEL CORPORATION   (United States)

^d VERTEX PHARMACEUTICALS   (United States)

Author keywords

Blood response; Hyaluronan; Platelet adhesion; RGD cell adhesive peptide; Stainless steel

Indexed keywords

BIOPOLYMERS; BLOOD; CELLS; CHEMICAL BONDS; EPOXY RESINS; HEART VALVE PROSTHESES; SILANES; STAINLESS STEEL; TISSUE;

COVALENT ATTACHMENTS; VASCULAR STENTS;

IMPLANTS (SURGICAL);

BIOPOLYMER; EPOXIDE; FLUORESCENT DYE; HYALURONIC ACID; SILANE; STAINLESS STEEL;

ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COVALENT BOND; DERIVATIZATION; EXTRACELLULAR MATRIX; HEMOSTASIS; HISTOCOMPATIBILITY; IMMUNE RESPONSE; METAL IMPLANTATION; PROTEIN PROTEIN INTERACTION; SURFACE PROPERTY; THROMBOCYTE ADHESION; TISSUE ENGINEERING; WOUND HEALING;

EID: 0348226583     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10170     Document Type: Article

References (66)

1. Helsen JA, Breme HJ, editors. Metals as biomaterials. Chichester: Wiley; 1998.
2. Weigel PH, Forst SJ, LeBoeuf RD, McGary CT. The specific interaction betweeen fibrin(ogen) and hyaluronan: Possible consequences in haemostasis, inflamation and wound healing. In: Evered D, Whelan J, editors. The biology of hyaluronan. Chichester, UK: J. Wiley & Sons, Ltd.; 1989. p 248-264.
3. Underhill CB. Interaction of HA with the cell surface. In: Evered D, Whelan J, editors. The biology of hyaluronan. Chichester, UK: J. Wiley & Sons, Ltd.; 1989. p 87-106.
4. Turley EA. The role of a cell-associated hyaluronan-binding protein in fibroblast behaviour. In: Evered D, Whelan J, editors. The biology of hyaluronan. Chichester, UK: J. Wiley & Sons, Ltd.; 1989. p 121-137.
5. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB 1993;7: 1233-1241.
6. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992;6:2397-2404.
7. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled chemical modification of hyaluronic acid: Synthesis, applications, and biodegradation of hydrazide derivatives. J. Controlled Release 1998;53:93-103.
8. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Chemical modification of hyaluronic acid for drug delivery, biomaterials and biochemical probes. In: Laurent TC, editor. The chemistry biology and medical applications of hyaluronan and its derivatives. London: Portland Press; 1998. p 43-65.
9. Hoekstra D. Hyaluronan-modified surfaces for medical devices. Med Device & Diagn Ind 1999;February:48-58.
10. Drobnik J. Hyaluronan in drug delivery. Adv Drug Del Res 1994;7:295-308.
11. Hamilton R, Fox EM, Acharya RA, Walts AE. Water insoluble derivatives of hyaluronic acid. 4,937,270 (US, 1990).
12. Morra M, Cassinelli C. Wettability and surface structure of hyaluronic acid and hyaluronic acid ester fouling-resistant coatings. In: ACS polymeric materials science and engineering. San Francisco, CA: ACS; 1997. p 566-567.
13. Scully MF, Kakkar VV, Goodwin CA, O'Regan M. Inhibition of fibrinolytic activity by hyaluronan and its alcohol ester derivatives. Thromb Res 1995;78:255-258.
14. Reijnen MM, van Goor H, Falk P, Hedgren M, Holmdahl L. Sodium hyaluronate increases the fibrinolytic response of human peritoneal mesothelial cells exposed to tumor necrosis factor alpha. Arch Surg 2001;36:291-296.
15. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998;19:2101-2127.
16. Koshiishi I, Shizari M, Underhill CB. CD44 can mediate the adhesion of platelets to hyaluronan. Blood 1994;84:390-396.
17. Kito H, Matsuda T. Biocompatible coatings for luminal and outer surfaces of small-caliber artificial grafts. J Biomed Mater Res 1996;30:321-330.
18. Chen G, Imanishi Y, Magnani A, Lamponi S, Barbucci R. Photoimmobilization of sulfated hyaluronic acid for anti-thrombogenicity. Bioconjugate Chem 1997;8:730-734.
19. Verheye S, Markou CP, Salame MY, Wan B, King SB, Robinson KA, Chronos NAF, Hanson SR. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000;20:1168-1172.
20. Abatangelo G, Barbucci R, Brun P, Lamponi S. Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives. Biomaterials 1997;18:1411-1415.
21. Weetall HH. Preparation of immobilized proteins covalently coupled through silane coupling agents to inorganic supports. Appl Biochem Biotechnol 1993;41:157-188.
22. Endo K. Chemical modification of metallic implant surfaces with biofunctional proteins (Part 1). Molecular structure and biological activity of a modified NiTi alloy surface. Dent Mater J 1995;14:185-198.
23. Nanci A, Wuest JD, Peru L, Brunet P, Sharma V, Zalzal S, McKee MD. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res 1998;40:324-335.
24. Puleo DA. Activity of enzyme immobilized on silanized Co-Cr-Mo. J Biomed Mater Res 1995;29:951-957.
25. Puleo DA. Retention of enzymatic activity immobilized on silanized Co-Cr-Mo and Ti-6AJ-4V. J Biomed Mater Res 1997; 37:222-228.
26. Rezania A, Johnson R, Lefkow AR, Healy KE. Bioactivation of metal oxide surfaces. 1. Surface characterization and cell response. Langmuir 1999;15:6931-6939.
27. Xiao S-J, Textor M, Spencer ND. Covalent attachment of cell-adhesive, (Arg-Gly-Asp)-containing peptides to titanium surfaces. Langmuir 1998;14:5507-5516.
28. Plueddemann EP. Silane coupling agents. New York: Plenum; 1991.
29. Puleo DA. Biochemical surface modificationof Co-Cr-Mo. Biomaterials 1996;17:217-222.
30. van Ooij AJ, Child T. Protecting metal with silane coupling agents. Chemtech 1998;28(2):26-35.
31. Puleo DA, Kissling RA, Sheu M-S. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002;23:2079-2087.
32. Keuren JF, Wielders SJ, Willems GM, Morra M, Cahalan L, Cahalan P, Lindhout T. Thrombogenicity of polysaccharide-coated surfaces. Biomaterials 2003;24:1917-1924.
33. Keuren JF, Wielders SJ, Willems GM, Morra M, Lindhout T. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood. Thromb Haemost 2002;87:742-747.
34. Ostuni E, Yan L, Whitesides GM. The interaction of proteins and cells with self-assembled monolayers of alkanethiolates on gold and silver. Colloid Surf B Biointeract 1999;15:3-30.
35. Delvaux M, Demoustier-Champagne S. Immobilisation of glucose oxidase within metallic nanotubes arrays for application to enzyme biosensors. Biosens Bioelectron 2003;18:943-951.
36. Fung YS, Wong YY. Self-assembled monolayers as the coating in a quartz piezoelectric crystal immunosensor to detect Salmonella in aqueous solution. Anal Chem 2001;73:5302-5309.
37. Cook AD, Hrkach JS, Gao NN, Johnson IM, Pajvani UB, Cannizzaro SM, Langer R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomat Mater Res 1997;35:513-523.
38. Tong YW, Shoichet MS. Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons. J Biomed Mater Res 1998;42:85-95.
39. Hubbell JA, Massia SP, Desai NP, Drumheller PD. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology 1991;9:568-572.
40. Massia SP, Hubbell J. Covalent surface immobilization of Arg-Gly-Asp and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal Biochem 1990; 187:292-301.
41. Porte-Durrieu MC, Labrugere C, Lefebvre F, Dutoya S, Guette A, Bordenave L. Development of RGD peptides grafted onto silica surfaces: XPS characterization and human endothelial cell interactions. J Biomed Mater Res 1999;46:368-375.
42. Horwitz AF. Integrins and health. Sci Am 1997;276(5):68-75.
43. Massia SP, Hubbell JA. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of the plasma fibronectin is mediated by integrin alpha4beta1. J Biol Chem 1992;267:14019-14026.
44. Marchand-Brynaert J, Detrait E, Noiset O, Boxus T, Schneider Y-J, Remacle C. Biological evaluation of RGD peptidomimetics, designed for the covalent derivatization of cell culture substrata, as potential promotors of cellular adhesion. Biomaterials 1999;20:1773-1782.
45. Curtis TM, McKeown-Longo PJ, Vincent PA, Homan SM, Wheatley EM, Saba TM. Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha5beta1, or TNF-alpha exposure. Am J Physiol 1995;269: L248-L260.
46. Roberts C, Chen CS, Mrksich M, Martichonok V, Ingber DE, Whitesides GM. Using mixed self-assembled monolayers presenting RGD and (EG)3OH groups to characterize long-term attachment of bovine capillary endothelial cells to surfaces. J Am Chem Soc 1998;120:6548-6555.
47. Wong JY, Weng Z, Moll S, Kim S, Brown CT. Identification and validation of a novel cell-recognition site (KNEED) on the 8th type III domain of fibronectin. Biomaterials 2002;23:3865-3870.
48. Cutler SM, Garcia AJ. Engineering cell adhesive surfaces that direct integrin alpha5beta1 binding using a recombinant fragment of fibronectin. Biomaterials 2003;24:1759-1770.
49. Kao WJ, Lee D, Schense JC, Hubbell JA. Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains. J Biomed Mater Res 2001;55: 79-88.
50. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
51. Schliephake H, Scharnweber D, Dard M, Rossler S, Sewing A, Meyer J, Hoogestraat D. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. Clin Oral Implants Res 2002;13:312-319.
52. Barber TA, Golledge SL, Castner DG, Healy KE. Peptide-modified p(AAm-co-EG/AAc) IPNs grafted to bulk titanium modulate osteoblast behavior in vitro. J Biomed Mater Res 2003;64: 38-47.
53. Zreiqat H, Akin FA, Howlett CR, Markovic B, Haynes D, Lateef S, Hanley L. Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfaces. J Biomed Mater Res 2003;64:105-113.
54. Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronic acid oligosaccharides: Drug carriers and novel biomaterials. Bioconj Chem 1994;5:339-347.
55. Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem 1999;10:755-763.
56. Luo Y, Ziebell MR, Prestwich GD. A hyaluronic acid-toxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 2000;1:208-218.
57. Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J Controlled Release 2000;69:169-184.
58. Mason M, Vercruysse KP, Kirker KR, Frisch R, Marecak DM, Prestwich GD, Pitt WG. Attachment of hyaluronic acid to polypropylene, polystyrene, and polytetrafluoroethylene. Biomaterials 2000;21:31-36.
59. Wan B, MacGregor H, Clavin M, Chang G, Shieldlin A, Nickerson C, Miller B, Skinner K. Evaluation of immobilized hyaluronic acid: Stability and platelet deposition studies. In: Society for biomaterials 228; Society for Biomaterials, Rhode Island Convention Center, Providence RI, 1999.
60. Hong J, Andersson J, Ekdahl KN, Elgue G, Axen N, Larsson R, Nilsson B. Titanium is a highly thrombogenic biomaterial: Possible implications for osteogenesis. Thromb Haemost 1999; 82:58-64.
61. Herrmann R, Schmidmaier G, Maerkl B, Resch A, Haehnel I, Stemberger A, Alt E. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999;82:51-57.
62. Foo RSY, Gershlick AH, Hoegrefe K, Baron JH, Johnston TW, Hussey AJ, Garner I, de Bono DP. Inhibition of platelet thrombosis using an activated protein C-loaded stent: In vitro and in vivo results. Thromb Haemost 2000;83:496-502.
63. Monnick SHJ, van Boven AJ, Peels HOJ, Tigchelaar I, de Kam PJ, Crijns HJGM, van Oeveren W. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Invest Med 1999;47:304-310.
64. Peter K, Schwarz M, Ylanne J, Kohler B, Moser M, Nordt T, Salbach P, Kubler W, Bode C. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa inhibitors. Blood 1998;92:3240-3249.
65. Wittig K, Rothe G, Schmitz G. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852. Thromb Haemost 1998;79: 625-630.
66. Pilloni A, Bernard GW. The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res 1998; 294:323-333.